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Machine learning with autophagy-
related proteins for discriminating 
renal cell carcinoma subtypes
Zhaoyue He1,2, He Liu1, Holger Moch3 & Hans-Uwe Simon  1,4*
Machine learning techniques have been previously applied for classification of tumors based largely 
on morphological features of tumor cells recognized in H&E images. Here, we tested the possibility 
of using numeric data acquired from software-based quantification of certain marker proteins, i.e. 
key autophagy proteins (ATGs), obtained from immunohistochemical (IHC) images of renal cell 
carcinomas (RCC). Using IHC staining and automated image quantification with a tissue microarray 
(TMA) of RCC, we found ATG1, ATG5 and microtubule-associated proteins 1A/1B light chain 3B (LC3B) 
were significantly reduced, suggesting a reduction in the basal level of autophagy with RCC. Notably, 
the levels of the ATG proteins expressed did not correspond to the mRNA levels expressed in these 
tissues. Applying a supervised machine learning algorithm, the K-Nearest Neighbor (KNN), to our 
quantified numeric data revealed that LC3B provided a strong measure for discriminating clear cell RCC 
(ccRCC). ATG5 and sequestosome-1 (SQSTM1/p62) could be used for classification of chromophobe 
RCC (crRCC). The quantitation of particular combinations of ATG1, ATG16L1, ATG5, LC3B and p62, all 
of which measure the basal level of autophagy, were able to discriminate among normal tissue, crRCC 
and ccRCC, suggesting that the basal level of autophagy would be a potentially useful parameter for 
RCC discrimination. In addition to our observation that the basal level of autophagy is reduced in RCC, 
our workflow from quantitative IHC analysis to machine learning could be considered as a potential 
complementary tool for the classification of RCC subtypes and also for other types of tumors for which 
precision medicine requires a characterization.
Autophagy, a dynamic catabolic process, characterized by the degradation of cellular contents in double 
membrane-forming autophagosomes, is well known for its essential roles in regulating cellular homeostasis1,2. 
The class III PI3K and mTOR pathways, as well as the so-called ATGs are key regulators of autophagy3. Although 
kept at relatively low level, autophagy can be induced by diverse stresses, e.g. growth factor withdrawal or admin-
istration of anti-cancer drugs. Interestingly, however, autophagy induced by anti-cancer therapy has two sided 
effects, either protecting cancer cells from drug-induced cell death, or promoting drug-induced cell death by 
inducing “autophagic cell death” in cancer cells3,4. With IHC staining of ATG5 and LC3 in paraffin sections 
derived from primary melanomas and testicular germ cell tumors, we found that both ATG5 expression and 
autophagy generally are downregulated in these cancer patients5,6. In a mouse model of lung cancer, it has been 
found that a deficiency in autophagy accelerates tumor initiation, favors, however, overall survival once a tumor 
is formed7.
RCC is composed of heterogeneous neoplastic cells arising from renal tubular epithelial cells and is the most 
lethal malignant urological tumor. The most frequent histological subtypes accounting for more than 90% of all 
RCCs are clear cell renal cell carcinomas (ccRCC), papillary renal cell carcinomas (pRCC) and chromophobe 
renal cell carcinomas (crRCC)8–10. Research efforts to identify molecular markers for discriminating among these 
subtypes suggest that histone methyltransferases and microRNA-145 may have diagnostic value for discrimina-
tion of certain subtypes of RCC11,12.
In contrast to the vast amounts of literature investigating the role of autophagy in anti-cancer therapy, research 
on the significance of the basal level of autophagy in tumors remains rare. In case of RCC, it has been reported 
that a combined analysis of several autophagy markers could contribute to a prediction of postoperative disease 
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recurrence in patients with ccRCC13. In RCC with characteristic cytoplasmic inclusions composed of protein 
aggregates and peroxisomes, somatic mutations or high frequencies of genetic variations in ATG7, ATG5 and 
ATG10 were found to be associated with the formation of these inclusions, suggesting a possible defect in auto-
phagy in these patients14.
Machine learning algorithms have been widely applied for the recognition of nuclei, for detection of tissue 
segmentation15, for breast cancer diagnosis16, and for classification and mutation prediction in lung cancer17. In 
contrast to the raw medical images as input data for machine learning used to now, the application of numeric 
data generated from the quantification of immunohistochemical images for machine learning has remained rare. 
Here, we have selected a simple and fast classification algorithm, the K-Nearest Neighbor (KNN) algorithm, 
for discrimination among RCC subtypes. Compared to other algorithms, KNN is easy to understand and to 
implement. For machine learning with KNN, we used the normalized Integrated Optical Density (IOD) values 
obtained from IHC staining of ATG proteins as features or variables and the patients diagnosed with different 
subtypes as observations. In this study, we show a significant downregulation of ATG1, ATG5 as well as LC3B in 
RCC by IHC staining followed by software-based quantification of the IODs of these autophagy marker proteins, 
suggesting a reduced basal level of autophagy in RCC patients in vivo. Our machine learning algorithm with the 
IODs thus obtained suggested that LC3B provided a strong measure for discriminating clear cell RCC (ccRCC). 
ATG5, and sequestosome-1 (SQSTM1 or p62) could be used for classification of chromophobe RCC (crRCC). A 
combination of ATG1, ATG16L1, ATG5, LC3B and p62, was able to discriminate among normal tissue, crRCC 
and ccRCC. Thus, our work indicates the potential for bioinformatics approaches in tumor classification based on 
the expression levels of certain ATGs in RCC.
Materials and Methods
Patient cohort and TMA. The TMA containing 237 RCCs from untreated patients and 18 normal kid-
ney tissues from healthy donors was constructed by the Department of Pathology and Molecular Pathology, 
University and University Hospital Zurich. All methods were performed in accordance with the relevant guide-
lines and regulations as previously described18.
iHc. IHC was performed as previously described5. Briefly, paraffin-embedded TMAs were deparaffin-
ized, rehydrated, and subjected to antigen retrieval. The Dako REAL Detection System, Alkaline Phosphatase/
RED kit was applied to stain the tissue sections according to the instructions provided (K5005, Dako). The 
Figure 1. The mRNA expression of key ATGs in RCC. The mRNA expression data for ATGs in RCC was 
obtained from the TCGA consortium data base presented here as normalized mRNA expression with means 
and SEMs. **p < 0.01; ***p < 0.001; ns, not significant.
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following antibodies were used: anti-ATG1 (AP8104b, Abgent), anti-ATG16L1 (LS-B2723, Lifespan Biosciences), 
anti-ATG5 (11C3, Nanotools), anti-LC3B (023–100, Nanotools) and anti-p62 (P0067, Sigma).
Quantification of the staining intensity. The staining intensities of the proteins of interests were quan-
tified as IODs with Image Pro Plus as described5.
Statistical analysis. The statistical analysis was performed with the unpaired Student t-test or ANOVA 
followed by the Bonferroni test for multiple comparisons as indicated. p < 0.05 is considered as statistically 
significant.
Machine learning with R. All data analysis was performed using the R language, including data cleaning 
and machine learning19. The data were centered and scaled by normalization with mean and SD values before 
submission to the machine learning algorithm. The K-Nearest Neighbor (KNN) algorithm was selected for 
machine learning20. Upon stratified sampling, 55% of the data were used for training and the remaining 45% were 
used for testing. Receiver Operating Characteristics (ROC) curves and Area Under Curve (AUC) values were 
calculated using the “pROC” package. Training data were used to build the KNN model with optimal K values 
determined by a 4-fold cross validation. The cross validation was performed using 4 subsets of training data gen-
erated by stratified sampling. Three of the subsets were used for training and one was used for testing. This process 
iterated 4 times until all subsets were tested for validating and optimizing the learning model. Next, testing data 
were passed to the model for prediction. The performance of the KNN models was measured by Accuracy and 
Kappa or Cohen’s Kappa values21 using the “caret” package. Accuracy showed the percentage of correctly classified 
instances out of all instances. Kappa is calculated by (po − pe)/(1 − pe), while po is the accuracy and pe is the hypo-
thetical probability of chance agreement. Kappa represented the accuracy normalized at the baseline of random 
chance on the dataset, serving to indicate the statistical inter-rater agreement.
ethical approval. Our retrospective study fulfilled the legal conditions according to Article 34 of the Swiss 
Law “Humanforschungsgesetz (HFG)”, which, in exceptional cases, allows the use of biomaterial and patient data 
for research purposes without informed consent, if i) it is impossible or disproportionately difficult to obtain 
patient consent; ii) there is no documented refusal; iii) research interests prevail over the individual interest 
of a patient. That the legal conditions of this study were abided to was reviewed and approved by the Ethics 
Commission of the Canton Zurich (KEK-ZH StV 25–2008, BASEC-Nr. PB_2016-02377).
Figure 2. IHC staining of ATGs and their quantification. Left panel: Representative images of IHC for ATG1, 
ATG16L1 and ATG5. Right panel: The IODs quantified with Image Pro Plus software are presented as means 
and SEMs.
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Results
Reduced expression of ATG1, ATG5 and LC3B in RCC. Based on the mRNA expression data available 
from The Cancer Genome Atlas (TCGA) consortium (https://cancergenome.nih.gov/), we compared the levels 
of the indicated ATGs in different subtypes of RCC and found that the transcripts of ATG1, ATG16L1, LC3B and 
p62 were increased in the tumor compared with the normal tissues (Fig. 1). However, the ATG5 mRNA level was 
decreased in the tumor compared with that found in the normal tissues (Fig. 1). Except ATG5, which showed 
similar levels among all RCC subtypes, the rest of the ATGs showed differential expression within RCC subtypes 
(Fig. 1).
Using TMAs containing 237 RCCs and 18 normal kidney tissues, however, we found a reduction in the protein 
expression of ATG1 and ATG5 in the tumor compared with the normal tissues by IHC staining (Fig. 2). No dif-
ference in ATG16L1 protein was detected between normal and the tumor tissues (Fig. 2). Within RCC subtypes, 
ATG1 and ATG16L1 are differentially expressed between crRCCs and ccRCCs, whereas ATG5 expression differed 
between crRCCs and pRCCs as well as between ccRCCs and pRCCs (Fig. 2). Staining LC3B, an autophagosome 
marker protein3 revealed a significant reduction in LC3B in the tumor compared to the normal tissues (Fig. 3a), 
suggesting a reduced basal level of autophagy in RCC. Interestingly, LC3B showed differential expression among 
all three subtypes of RCCs (Fig. 3a). Although, p62, which is degraded through the process of autophagy3 does 
not show differential expression between the normal and the tumor tissues, its expression differed between 
crRCCs and ccRCCs as well as between crRCCs and pRCCs (Fig. 3b). Interestingly, RCCs, ccRCCs and pRCCs 
with low p62 expression showed better survivals than those with high levels of p62 (Fig. 3c), suggesting the prog-
nostic value of p62 probably due to its autophagy-unrelated functions. However, other investigated ATGs did not 
correlate with patient survival (data not shown). In contrast to mRNA analysis, showing an overall increase in 
the gene expression of the ATGs (Fig. 1), our evaluation of protein expression by corresponding ATGs suggested 
however, that autophagy was decreased in RCCs (Figs. 2 and 3). Often mRNA levels of a gene do not correlate 
with that of the protein expression due to e.g. regulation of mRNA stability and/or translational repression. It 
has been shown that ATG1 and LC3 mRNAs are stabilized by repression of protein synthesis, thus serving as a 
pool in order to rapidly replenish ATG proteins required for starvation-induced autophagy22. This may explain 
at least partially the discrepancy between the TCGA mRNA expression data and our protein expression results. 
Figure 3. (a,b), Representative images of IHC staining of LC3B and p62 and their quantification presented as 
means and SEMs. (c) Survival curves of the RCC patients with high and low levels of p62. Scale bars: 50 µm. 
Statistical analysis among RCC subtypes was performed with ANOVA followed by the Bonferroni test for 
multiple comparisons. *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant.
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Therefore, it is essential to evaluate the level of autophagy based on protein expression rather than mRNA expres-
sion of essential ATGs.
Autophagy and specific ATGs are adequate predictive markers for RCC subtypes. To evaluate 
whether autophagy and ATGs can be good measures for discriminating RCC subtypes, we applied the IODs of 
the corresponding ATGs to the KNN algorithm. To investigate the classification potential of each protein in dif-
ferent tumor subtypes against normal tissue, we plotted ROC curves and AUC values for each protein (Fig. 4a). In 
ccRCC, ATG1, ATG5 and LC3B showed high AUC values suggesting their potential to distinguish ccRCC from 
the normal kidney tissue. Similarly, ATG5, ATG16L1 and p62 showed high AUC values in subgroup of crRCC. 
In contrast, only ATG1 showed high AUC values in case of pRCC. To avoid imbalance among different sample 
sizes of our RCC subtypes and normal tissues, we used a stratified sampling approach and then divided the data 
obtained into two groups: 55% for training and the remaining 45% for testing. We performed a 4-fold cross vali-
dation with the training data to find the optimal K values to be used for building the KNN model (Supplementary 
Table 1). We tested our models using the testing data. Consistently with ROC curves, the proteins showed similar 
performance in distinguishing different subtypes from the normal tissue based on the Accuracy and Kappa values 
(Fig. 4b). Next, we combined all subgroups of RCC and normal tissue with values for all five proteins and repeated 
the same learning process to study the performance of our model in discrimination of the mixed tissues. Results 
of Accuracy and Kappa values showed that our study had a good performance, indicating that machine learning 
with the combination of these proteins could be used to distinguish different kidney tissues containing both 
tumors and normal tissues. Additionally, as most of the tested proteins could not differentiate pRCC from normal 
tissue, our model could even be improved if pRCC was not included (Fig. 4c), suggesting that evaluation of auto-
phagy and/or ATGs are less sufficient for pRCC prediction as compared with other subtypes. In this case, other 
marker proteins, either related or unrelated to autophagy, need to be included in order to discriminate pRCC.
Figure 4. Machine learning to distinguish among RCC subtypes. (a) The ROC curves are shown for 3 tumor 
subtypes containing normal tissue. AUC values from different proteins are also presented on the plot. (b) 
Accuracy and Kappa values of the indicated ATGs or all 5 together (All) for discriminating RCC subtypes 
are presented. (c) Accuracy and Kappa values are presented as a measure of the performance of the machine 
learning algorithm with the total experimental data compared to the manipulated data excluding pRCC.
6Scientific RepoRtS |          (2020) 10:720  | https://doi.org/10.1038/s41598-020-57670-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Discussion
Although visual inspection of histopathological tissue samples by pathologists is still the standard approach to 
classification of tumor subtypes, recently developed computational approaches including automatic image pro-
cessing and machine learning techniques may dramatically change the routine work flow of pathological diag-
nosis in the future. Despite the small sample size, we provided evidence that the quantified numeric data are also 
suitable for machine learning that does not require a sophisticated machine learning algorithm to discriminate 
RCC subtypes. Engaging machine learning in quantitative image analysis that allows an objective evaluation of 
the expression of the target proteins is rare. Our approach from IHC staining of ATGs, quantification of ATG 
expression to the application of machine learning algorithm, would assist pathologists and clinicians in patients’ 
classification and might contribute to targeted therapy. With increasing numbers of cases that can be used as 
training data, our protocol will be optimized to increase the recall and precision of the prediction, thus represent-
ing a quantitative means in precision medicine.
In this work, we have evaluated the expression of the key ATGs in RCCs by IHC and have quantified the 
obtained images that were later applied as numeric data to an R-based machine learning algorithm to classify the 
subtypes of RCCs. We have found a reduction in the basal level of autophagy in tumors as evidenced by reduced 
expression of ATG1, ATG5 and LC3B. Furthermore, LC3B provided a strong measure to discriminate ccRCC. 
ATG5 and p62 could be used for classification of crRCC. The combination of all these markers was able to predict 
normal tissue, crRCC and ccRCC, thus suggesting that the basal level of autophagy could be a potential measure-
ment for RCC discrimination. Our workflow using quantified image analysis together with a machine learning 
algorithm may have clinical implications for modern pathology and precision medicine.
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